ArticleFrontiers in pharmacology2024

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.

Qiong Jie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.